It is indicated for the treatment of infection by Cryptosporidium parvum and Giardia lamblia in immunocompetent individuals and has been repurposed for the treatment of influenza.
This medication is suggested for the management of parasitic infections in people with normal immune systems, caused by Cryptosporidium parvum and Giardia lamblia, and has been adapted for the treatment of flu-like illnesses.